These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33886614)

  • 1. High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.
    Choi R; Zhou M; Shek R; Wilson JW; Tillery L; Craig JK; Salukhe IA; Hickson SE; Kumar N; James RM; Buchko GW; Wu R; Huff S; Nguyen TT; Hurst BL; Cherry S; Barrett LK; Hyde JL; Van Voorhis WC
    PLoS One; 2021; 16(4):e0250019. PubMed ID: 33886614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.
    Canal B; Fujisawa R; McClure AW; Deegan TD; Wu M; Ulferts R; Weissmann F; Drury LS; Bertolin AP; Zeng J; Beale R; Howell M; Labib K; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2465-2479. PubMed ID: 34198324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
    Savale RU; Bhowmick S; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Patil PC; Islam MA
    Arch Biochem Biophys; 2021 Mar; 700():108771. PubMed ID: 33485847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repositioning to target NSP15 protein on SARS-CoV-2 as possible COVID-19 treatment.
    Sixto-López Y; Martínez-Archundia M
    J Comput Chem; 2021 May; 42(13):897-907. PubMed ID: 33713492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
    Hu LC; Ding CH; Li HY; Li ZZ; Chen Y; Li LP; Li WZ; Liu WS
    J Food Biochem; 2022 May; 46(5):e14085. PubMed ID: 35128681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
    Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
    Al-Rashedi NAM; Munahi MG; Ah ALObaidi L
    J Biomol Struct Dyn; 2022 Jul; 40(11):4879-4892. PubMed ID: 33357040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2.
    Kim Y; Wower J; Maltseva N; Chang C; Jedrzejczak R; Wilamowski M; Kang S; Nicolaescu V; Randall G; Michalska K; Joachimiak A
    Commun Biol; 2021 Feb; 4(1):193. PubMed ID: 33564093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural-based virtual screening and
    Ibrahim IM; Elfiky AA; Mahmoud SH; ElHefnawi M
    J Biomol Struct Dyn; 2024 Oct; 42(17):9145-9158. PubMed ID: 37615430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coronavirus nsp15 endoribonuclease: A puzzling protein and pertinent antiviral drug target.
    Van Loy B; Stevaert A; Naesens L
    Antiviral Res; 2024 Aug; 228():105921. PubMed ID: 38825019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
    Zeng J; Weissmann F; Bertolin AP; Posse V; Canal B; Ulferts R; Wu M; Harvey R; Hussain S; Milligan JC; Roustan C; Borg A; McCoy L; Drury LS; Kjaer S; McCauley J; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2405-2423. PubMed ID: 34198322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease.
    Canal B; McClure AW; Curran JF; Wu M; Ulferts R; Weissmann F; Zeng J; Bertolin AP; Milligan JC; Basu S; Drury LS; Deegan TD; Fujisawa R; Roberts EL; Basier C; Labib K; Beale R; Howell M; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2445-2464. PubMed ID: 34198326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
    Batool A; Bibi N; Amin F; Kamal MA
    Eur J Pharmacol; 2021 Feb; 892():173779. PubMed ID: 33275961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations.
    Zrieq R; Ahmad I; Snoussi M; Noumi E; Iriti M; Algahtani FD; Patel H; Saeed M; Tasleem M; Sulaiman S; Aouadi K; Kadri A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase.
    Basu S; Mak T; Ulferts R; Wu M; Deegan T; Fujisawa R; Tan KW; Lim CT; Basier C; Canal B; Curran JF; Drury LS; McClure AW; Roberts EL; Weissmann F; Zeisner TU; Beale R; Cowling VH; Howell M; Labib K; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2481-2497. PubMed ID: 34198328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease.
    Milligan JC; Zeisner TU; Papageorgiou G; Joshi D; Soudy C; Ulferts R; Wu M; Lim CT; Tan KW; Weissmann F; Canal B; Fujisawa R; Deegan T; Nagaraj H; Bineva-Todd G; Basier C; Curran JF; Howell M; Beale R; Labib K; O'Reilly N; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2499-2515. PubMed ID: 34198327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry.
    Pearson LA; Green CJ; Lin D; Petit AP; Gray DW; Cowling VH; Fordyce EAF
    SLAS Discov; 2021 Jul; 26(6):749-756. PubMed ID: 33724070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
    Watashi K
    Biochem Biophys Res Commun; 2021 Jan; 538():137-144. PubMed ID: 33272566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease.
    Chen J; Farraj RA; Limonta D; Tabatabaei Dakhili SA; Kerek EM; Bhattacharya A; Reformat FM; Mabrouk OM; Brigant B; Pfeifer TA; McDermott MT; Ussher JR; Hobman TC; Glover JNM; Hubbard BP
    J Biol Chem; 2023 Nov; 299(11):105341. PubMed ID: 37832873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.